Richard Bernstein Advisors’s Quest Diagnostics DGX Stock Holding History

Richard Bernstein Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,650	Closed	-$3.46M	–	218
2023 Q2	$3.46M	Hold	24,650	–	–	0.07%	88
2023 Q1	$3.49M	Hold	24,650	–	–	0.07%	99
2022 Q4	$3.86M	Buy	24,650 +16,020	+186%	+$2.3M	0.09%	93
2022 Q3	$1.06M	Sell	8,630 -5,101	-37%	-$672K	0.03%	188
2022 Q2	$1.83M	Hold	13,731	–	–	0.04%	177
2022 Q1	$1.88M	Hold	13,731	–	–	0.04%	198
2021 Q4	$2.38M	Hold	13,731	–	–	0.05%	191
2021 Q3	$2M	Hold	13,731	–	–	0.04%	208
2021 Q2	$1.81M	Hold	13,731	–	–	0.04%	208
2021 Q1	$1.76M	Sell	13,731 -7,080	-34%	-$872K	0.04%	214
2020 Q4	$2.48M	Hold	20,811	–	–	0.06%	178
2020 Q3	$2.38M	Hold	20,811	–	–	0.07%	150
2020 Q2	$2.37M	Sell	20,811 -4,763	-19%	-$505K	0.07%	146
2020 Q1	$2.05M	Sell	25,574 -8,610	-25%	-$891K	0.07%	138
2019 Q4	$3.65M	Hold	34,184	–	–	0.12%	127
2019 Q3	$3.66M	Hold	34,184	–	–	0.12%	129
2019 Q2	$3.48M	Hold	34,184	–	–	0.12%	137
2019 Q1	$3.07M	Buy	+34,184	New	+$2.96M	0.1%	177

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Richard Bernstein Advisors's DGX Position: Q3 2023 in Review

Richard Bernstein Advisors sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 24,650 shares — an estimated $3.46M sold.

Richard Bernstein Advisors first reported a position in DGX in Q1 2019 and held it in 18 quarters. The position peaked at $3.86M in Q4 2022. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

Richard Bernstein Advisors reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
Richard Bernstein Advisors sold 24,650 Quest Diagnostics shares in Q3 2023, an estimated $3.46M.
Richard Bernstein Advisors first reported a position in Quest Diagnostics in Q1 2019 and held it in 18 quarters.
Richard Bernstein Advisors's Quest Diagnostics position peaked at $3.86M in Q4 2022.
794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Richard Bernstein Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.